Senior Specialist
Merck & Co., Inc.
My name is Dr. Matthew Moye, Senior Specialist within Quantitative Pharmacology & Pharmacometrics (QP2) at Merck & Co., Inc. I obtained my Bachelors of Science in Quantitative Biology from the University of Delaware in 2014 and earned my PhD in Mathematical Sciences from New Jersey Institute of Technology. My PhD work focused on applying data assimilation algorithms, popularized by their use in weather prediction, to parameterize conductance-based models of circadian neurons. I joined Merck as a postdoctoral fellow in 2020 developing QSP models for neurodegeneration. I was promoted in 2022 and have since developed as a neuroscience QP2 therapeutic area specialist while providing modeling support across Merck's pipeline and platform efforts.